Incidence and clinical predictors of cranial nerve palsies (CNPs) post ciltacabtagene-autoleucel (cilta-cel) in patients with relapsed or refractory multiple myeloma (RRMM).

Authors: Karla Feliciano Salva, Christina Copponex, Junmin Whiting, Jongphil Kim, Mariola A. Vazquez Martinez, Doris K. Hansen, Omar Castañeda Puglianini, Hien Liu, Taiga Nishihori, Ariel Grajales-Cruz, Michael David Jain, Aleksandr Lazaryan, Frederick L. Locke, Kenneth H. Shain, Brandon Jamaal Blue, Muhammad Jaffer, Sepideh Mokhtari, Ciara L. Freeman, Rachid C. Baz, Melissa Alsina

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19508

Source: Full article

---

Abstract

e19508